Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 11 Mar 24 EFFECT Notice of effectiveness
-
1 Mar 24 POS AM Prospectus update (post-effective amendment)
- 8 Nov 23 424B3 Prospectus supplement
- 4 May 23 424B3 Prospectus supplement
- 27 Mar 23 EFFECT Notice of effectiveness
- 23 Mar 23 POS AM Prospectus update (post-effective amendment)
- 9 Nov 22 424B3 Prospectus supplement
- 3 Aug 22 424B3 Prospectus supplement
- 27 Apr 22 424B3 Prospectus supplement
- 11 Mar 22 EFFECT Notice of effectiveness
- 9 Mar 22 POS AM Prospectus update (post-effective amendment)
- 11 Feb 22 424B3 Prospectus supplement
- 11 Feb 22 EFFECT Notice of effectiveness
- 4 Feb 22 S-1 IPO registration
GOVX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Post-Effective Amendment No. 3 to the Registration Statement (No. 333-262541) on Form S-1 of GeoVax Labs, Inc. of our report dated February 29, 2024, relating to the 2023 consolidated financial statements and schedule of GeoVax Labs, Inc. which report expresses an unqualified opinion and includes an explanatory paragraph relating to going concern, appearing in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ WIPFLI LLP
Atlanta, Georgia
March 1, 2024